STAAR Surgical Ends Merger with Alcon After Shareholder Vote Fails
STAAR Surgical has terminated its merger agreement with Alcon after failing to secure enough shareholder votes, despite an increased $1.6 billion offer. This decision leaves STAAR to navigate standalone operations amid declining revenue and collapsed China sales.
Insights:
STAAR Surgical Company announced on January 6 that it has terminated its merger agreement with Alcon Inc. after failing to secure sufficient shareholder approval. The decision comes despite Alcon's increased offer of $1.6 billion, up from an original valuation of $1.5 billion, which was insufficient to sway shareholders in favor of the deal.
